Poor graft function (PGF) is a severe complication of allogeneic haematopoietic stem cell transplantation (allo-HSCT). Murine studies have demonstrated that effective haematopoiesis depends on the specific bone marrow (BM) microenvironment. Increasing evidence shows that BM macrophages (MФs), which constitute an important component of BM immune microenvironment, are indispensable for the regulation of haematopoietic stem cells (HSCs) in the BM. However, little is known about the number and function of BM MФs or whether they directly interact with HSCs in PGF patients. In the current prospective case-control study, PGF patients showed a significant increase in classically activated inflammatory MФs (M1; 2Á18 AE 0Á11% vs. 0Á82 AE 0Á06%, P < 0Á0001), a striking reduction in alternatively activated anti-inflammatory MФs (M2; 3Á02 AE 0Á31% vs. 21Á89 AE 0Á90%, P < 0Á0001), resulting in a markedly increased M1/M2 ratio (0Á82 AE 0Á06 vs. 0Á06 AE 0Á002; P < 0Á0001) in the BM compared with good graft function patients. Meanwhile, standard monocyte subsets were altered in PGF patients. Dysfunctional BM MФs, which were characterized by reduced proliferation, migration and phagocytosis, were evident in PGF patients. Furthermore, BM MФs from PGF patients with high tumour necrosis factor-a and interleukin 12 levels and low transforming growth factor-b levels, led to impaired BM CD34 + cell function. In summary, our data indicate that an unbalanced BM M1/M2 ratio and dysfunctional MФs may contribute to the occurrence of PGF following allo-HSCT.
prospective case-control studies demonstrate that the BM endosteal, vascular and immune microenvironment are impaired in PGF patients compared with good graft function (GGF) patients following allo-HSCT (Kong et al, 2013 (Kong et al, , 2016a Shi et al, 2016) . Therefore, our previous studies indicate that the impaired BM microenvironment may be involved in the pathogenesis of PGF through the disruption of the normal haematopoietic recovery of the transplanted donor's HSCs in PGF patients following allo-HSCT.
Macrophages (MФs), which constitute an important component of the BM immune microenvironment, are indispensable for the maintenance and retention of HSCs and erythroid output in BM (Mercier et al, 2011; Riether et al, 2015) . Two major MФ subpopulations with different functions, namely, the classically activated inflammatory MФ (M1) and alternatively activated anti-inflammatory MФ (M2), have been recognized (Mercier et al, 2011; Moghaddam et al, 2018) . In general, M1 express the CD68 MФ marker and chemokine-C receptor-2 (CCR2), while M2 typically express the MФ marker chemokine-X3C receptor-1 (CX3CR1) and scavenger receptor CD163 (Mantovani et al, 2009 ). M1 and M2 exert distinct functions (Moghaddam et al, 2018) . M1 mediate the defence of the host from a variety of bacteria, protozoa and viruses and have roles in antitumour immunity. M1 produce and secrete higher levels of pro-inflammatory cytokines, such as tumour necrosis factor a (TNF-a), interleukin (IL)-1a, IL-1b, IL-6, and IL-12. M2, which are characterized by low IL-12 production and high IL-10 and transforming growth factor b (TGF-b) production, have anti-inflammatory functions and regulate wound healing (Murray & Wynn, 2011; Wynn & Vannella, 2016) .
Murine and in vitro studies have shown that BM MФs contribute to HSC maintenance and erythropoiesis. The depletion of BM endosteal MФs using clodronate liposomes leads to HSC egress into the peripheral blood (Winkler et al, 2010) . CD169 + MФs contribute to the retention of HSCs in BM by activating Nestin + mesenchymal stem cells (Chow et al, 2011; Ludin et al, 2012) . Meanwhile, murine studies suggest that MФs are indispensable for BM erythroid maturation and output, resulting in increased erythroid yield (Chow et al, 2013; Falchi et al, 2015) . However, whether BM MФs directly interact with HSCs in PGF patients following allo-HSCT remains largely unknown. Multiple MФ-associated cytokines are involved in abnormal haematopoietic development. TNF-a overexpression has been proposed to be involved in the pathophysiology of BM failure disorders, especially in myelodysplastic syndromes and Fanconi anaemia Zhou et al, 2007; Du et al, 2014) . Murine studies have shown that elevations in proinflammatory cytokines, such as TNF-a and IL-12, can regulate haematopoiesis through the p53 (also termed TP53), p38 mitogen activated protein kinase (MAPK, also termed MAPK14), and NF jB pathways (Uyanik et al, 2017) . However, whether the MФ-associated cytokines are involved in regulating the function of BM HSCs in PGF patients remains to be elucidated.
In the current prospective case-control study, we evaluated whether the quantity of standard monocyte subsets and polarized M1/M2 and their function differed between PGF patients and GGF patients. Moreover, we determined whether the unbalanced BM M1/M2 directly interacted with HSCs in PGF patients and investigated its underlying molecular mechanism. Our aim was to provide new insights into the pathogenesis underlying PGF after allo-HSCT.
Methods

Patients and controls
In this prospective case-control study, cases were identified from patients who underwent allo-HSCT for haematological malignancies between 1 January 2017 and 31 January 2018, at Peking University Institute of Hematology. A total of 25 patients who had developed PGF after allo-HSCT were eligible. For each case, 2 matched controls with GGF (N = 50) were selected at random from the same cohort at the onset of PGF and were matched according to the following criteria: age at HSCT (AE1 year), pre-HSCT cycles of chemotherapy (AE1 cycle), disease status at allo-HSCT, and time of BM microenvironment evaluation after allo-HSCT (AE5 days) ("risk-set sampling") (Wacholder et al, 1992) . The characteristics of the PGF patients and GGF controls are summarized in Table I .
Bone marrow samples from 25 age-and sex-matched healthy donors (HD) for allo-HSCT were used as healthy controls. The healthy control group comprised 16 males and 9 females, ranging in age from 18 to 50 years (median, 38 years). The study was approved by the Ethics Committee of Peking University People's Hospital, and written informed consent was obtained from all patients and healthy donors before study entry, in accordance with the Declaration of Helsinki.
Clinical definitions and evaluation
Poor graft function was defined as the presence of 2 or 3 cytopenic counts (absolute neutrophils <0Á5 9 10 9 /l, platelets ≤20 9 10 9 /l, or haemoglobin ≤70 g/l) for at least 3 consecutive days beyond day +28 post-transplantation with a transfusion requirement, associated with hypoplastic-aplastic BM, in the presence of complete donor chimerism (Kong et al, 2013 (Kong et al, , 2016a (Kong et al, ,b, 2017 Shi et al, 2016; Wang et al, 2016) . Patients with evidence of severe graft-versus-host disease (GvHD) or haematological relapse after transplantation were excluded. GGF was defined as a persistent successful engraftment, as marked by an absolute neutrophil cell count >0Á5 9 10 9 /l for 3 consecutive days without granulocyte colony-stimulating factor administration, a platelet count >20 9 10 9 /l for 7 consecutive days without platelet transfusion, and a haemoglobin level >70 g/l without red blood cell transfusion, beyond day +28 post-HSCT (Kong et al, 2013 (Kong et al, , 2014 (Kong et al, , 2016a (Kong et al, ,b, 2018a . Chimerism analyses were performed by DNA fingerprinting for short tandem repeats in blood samples and/or by ALL, acute lymphocytic leukaemia; allo-HSCT, allogeneic haematopoietic stem cell transplantation; AML, acute myeloid leukaemia; ANC, absolute neutrophil count; ATG, anti-thymocyte globulin; BM, bone marrow; BU, busulfan; CMV, cytomegalovirus; CY, cyclophosphamide; GGF, good graft function; GvHD, graft-versus-host disease; Hb, haemoglobin; HLA, human leucocyte antigen; M1, classically activated inflammatory macrophages; M2, alternatively activated anti-inflammatory macrophages; MDS, myelodysplastic syndrome; PB, peripheral blood; PGF, poor graft function; SEM, standard error of the mean; TNC, total nucleated cell; WBC, white blood cell. *Group matching criteria included age at allo-HSCT (AE1 year), pre-HSCT cycles of chemotherapy (AE1 cycle), disease status at HSCT and BM microenvironment evaluated time after allo-HSCT (AE5 days). For each case, two GGF controls were randomly selected from the same cohort at which the PGF occurred ("risk-set sampling"). † The continuous variables were compared using the Mann-Whitney U-test, and the differences in frequency between the 2 groups were compared using the chi-square test. The criterion for statistical significance was P < 0Á05. (Wang et al, 2014a) .
Dysregulated BM M1/M2 Polarization in PGF Patients
Transplantation protocols
Donor selection, human leucocyte antigen (HLA)-typing, graft harvesting, conditioning therapy, and GvHD prophylaxis were performed as previously reported (Xu et al, 2018; Wang et al, 2104b) . The transplanted grafts comprised recombinant human granulocyte colony-stimulating factor (rhG-CSF)-mobilized peripheral blood stem cells and BM cells from matched or mismatched sibling donors. For all allo-HSCT procedures except for matched sibling transplantations, rhG-CSF was subcutaneously administered to patients at 5 lg/kg/day from day +6 until the neutrophil count reached 0Á5 9 10 9 /l for 3 consecutive days. Red blood cell or platelet transfusions were required for patients whose haemoglobin levels fell to <70 g/l or whose platelet counts were <20 9 10 9 /l, respectively.
Ciclosporin, mycophenolate mofetil and short-term methotrexate were used for GvHD prophylaxis after transplantation. Weekly real-time quantitative polymerase chain reaction (PCR) for detecting cytomegalovirus (CMV) DNA was used to evaluate CMV reactivation in the blood after allo-HSCT. Cytomegalovirus infections were treated with ganciclovir or foscarnet as previously described.
Isolation, identification and characterization of monocyte subsets
Bone marrow mononuclear cells (BMMNCs) were isolated by density gradient centrifugation using lymphocyte separation medium (GE Healthcare, Milwaukee, WI, USA). The identification of monocyte subsets was performed using multiparameter flow cytometry. For analysis of classical, intermediate and non-classical monocytes, cells were stained with a phycoerythrin (PE) anti-CD14 monoclonal antibody (mAb) and an allophycocyanincyanin 7 (APC-Cy7) anti-CD16 mAb (BioLegend, San Diego, CA, USA). The analysis was performed according to a standardized gating strategy (Ziegler-Heitbrock et al, 2010) . For more definite monocyte subsets, fluorescein isothiocyanate (FITC) anti-CD68 mAb and brilliant violet 421 (BV421) anti-CCR2 mAb (BioLegend) were used for the identification of M1 cells, and peridinin chlorophyll-cyanin 5.5 (PerCP/Cy5.5) anti-CX3CR1 and PE/Cy7 anti-CD163 (BioLegend) mAbs were used for the identification of M2 cells. The relative frequencies of these monocyte subsets were expressed as percentages of the total monocyte gate.
In vitro macrophage differentiation
Bone marrow CD14 + monocytes were isolated from BMMNCs using CD14 + MACS (Miltenyi Biotec, Bergisch Gladbach, Germany) according to the manufacturer's instructions. The purity of monocytes isolated using this method was evaluated by flow cytometry and was routinely >98%. Histological analysis of the human BM microenvironment
As previously described (Duan et al, 2014; Kong et al, 2018b) , the immunofluorescence staining of the BM trephine biopsies were performed with the mouse anti-human CD68 (Abcam, Cambridge, MA, USA) and rabbit anti-human CD163 (Abcam) antibodies. 4 0 ,6-Diamidino-2-phenylindole (DAPI) was applied to stain the nuclei, and the slides were analysed under a Leica TCS SP8 microscope (Leica Microsystems, Wetzlar, Germany).
Phagocytosis of modified low-density lipoprotein (LDL) particles
As previously described (Shi et al, 2016; Kong et al, 2018b) , phagocytosis of modified LDL particles was examined after 7 days of cultivation. Three power fields were randomly counted to evaluate the percentage of BMMo-MФs per well that were positive for Dil-acetylated low-density lipoprotein (DiI-AcLDL; Life Technologies, Gaithersburg, MD, USA) using a fluorescence microscope (Olympus, Tokyo, Japan).
Migration assay
Cell migration was assessed using a Transwell chamber (Corning Inc., Corning, NY, USA). The cells were trypsinised and seeded to the upper chambers at a density of 5 9 10 4 cells per well, while 500 ml of medium was added to the lower chambers. The cells were cultured for 24 h, and migrated cells were fixed with paraformaldehyde for 30 min. Then, the cells on the lower surfaces of the membranes were stained with crystal violet for 20 min. Cell images were obtained on a phase-contrast microscope (Olympus), and cells were counted manually in three random fields/sample. 
Coculture of BM CD34 + cells with BMMo-MФs
Apoptosis analysis
To detect apoptosis, non-adherent CD34 + cells that were stained with PE anti-CD34 mAb were assessed with the Annexin-V and 7-amino-actinomycin D Apoptosis Detection Kit (Becton Dickinson) according to the manufacturer's instructions.
Measurement of intracellular reactive oxygen species (ROS) levels
After 5 days of cocultivation, nonadherent CD34 + cells stained with PE anti-CD34 mAb were incubated with 10 lmol/l 2 0 ,7 0 -dichlorofluorescence diacetate (Byotimes, Shanghai, China) at 37°C for 15 min. The mean fluorescence intensity (MFI) of intracellular ROS was analysed on a BD LSRFortessa (Becton Dickinson) (Kong et al, 2016b (Kong et al, , 2018a Shi et al, 2016) .
Colony-forming unit (CFU) assays
Colony-forming units were assessed using MethoCultH4434 Classic (Stem Cell Technologies). After 5 days of cocultivation, nonadherent CD34 + cells were harvested, and 2 9 10 3 cells were plated in 24-well plates and cultured for 14 days. Colony-forming unit erythroid (CFU-E), burst-forming unit erythroid (BFU-E), colony-forming unit granulocyte-macrophage (CFU-GM) and colony-forming unit granulocyte, erythroid, macrophage and megakaryocyte (CFU-GEMM) measurements were scored on an inverted light microscope. Cultures were assessed in duplicate, and the results were expressed as the mean and standard error of the mean (SEM).
Cytokine production assays
BMMo-MФs were cultured in Roswell Park Memorial Institute (RPMI) medium and then incubated with lipopolysaccharide (100 ng/ml) at 37°C for 24 h. The presence of intracellular cytokines in BMMo-MФs was determined by flow cytometry. The coculture supernatants of the BMMo-MФs and BM CD34 + cells were harvested, and the TNF-a levels were measured by enzyme-linked immunosorbent assay (R&D Systems Inc, Minneapolis, MN, USA).
Intracellular protein detection by flow cytometry
After 5 days of cocultivation, nonadherent CD34 + cells were incubated with CD34 markers at 4°C for 15 min and then fixed, permeabilised and incubated with phosphor(p)-p38, p-ERK and p-JNK antibodies (Cell Signaling Technology, Danvers, MA, USA). The intracellular protein levels were analysed using LSRFortessa software (Becton Dickinson) and expressed as the MFI (mean AE SEM).
Statistical analysis
Statistical analyses were performed using one-way analysis of variance (ANOVA) for comparisons among the groups. Subject variables were compared using the v 2 test for categorical variables and the Mann-Whitney U test for continuous variables. Analyses were performed using GraphPad Prism 6.0 (GraphPad Software, La Jolla, CA, USA), and P values <0Á05 were considered statistically significant.
Results
Patient characteristics
Twenty-five PGF patients and 50 matched GGF patients after allo-HSCT were enrolled in the current prospective case-control study. Complete donor chimerism was confirmed by PCR-based DNA fingerprinting of short tandem repeats in BM cells at the time of PGF. As shown in Table I , none of the demographic and clinical characteristics, including age, sex, underlying disease, pretransplantation disease status, median time from diagnosis to transplantation, stem cell source, transplanted total nucleated cell dose, CD34 + cell dose, donor HLA match, gender/ABO mismatch, pretransplantation cycles of chemotherapy, conditioning, history of GvHD or CMV, and duration of anti-CMV therapy, showed significant differences between the allo-HSCT patients with PGF and those with GGF. (Fig 1A) . The baseline percentages of classical monocytes in PGF patients were significantly lower than those in GGF patients (Fig 1B; 12Á19 AE 0Á96% vs. 32Á81 AE 0Á98%, P < 0Á0001). Elevated intermediate monocyte subsets (Fig 1C; 3Á03 AE 0Á22% vs. 2Á00 AE 0Á12%, P = 0Á0002) and non-classical monocyte subsets (Fig 1D; 14Á96 AE 0Á84% vs. 2Á24 AE 0Á16%, P < 0Á0001) were observed in PGF patients compared with in GGF patients. Briefly, PGF patients displayed alterations in the proportion of BM standard monocyte subsets compared with the GGF patients and HD.
Reduced percentage of classical monocytes and increased percentages of intermediate and non-classical monocytes in the BM of PGF patients
PGF patients displayed an unbalanced M1/M2 ratio compared with GGF patients and HD M1 (CD68 + CCR2 + ) and M2 (CX3CR1 + CD163 + ) were further analysed (Fig 2A) . PGF patients showed a significant increase (Fig 2B; 2Á18 AE 0Á11% vs. 0Á82 AE 0Á06%, P < 0Á0001) and a striking reduction in M2 (Fig 2C; 3Á02 AE 0Á31% vs. 21Á89 AE 0Á90%, P < 0Á0001) compared with GGF patients. As a result, the M1/M2 ratio was markedly increased in PGF patients compared with GGF patients (Fig 2D; 0Á82 AE 0Á06 vs. 0Á06 AE 0Á002, P < 0Á0001).
In situ histological analyses of the BM trephine biopsies were performed to further characterize the BM MФs. Consistent with our flow cytometry data, the immunofluorescence staining (Fig 3) revealed that CD68 + BM MФs were significantly increased, whereas CD163 + BM MФs were significantly reduced in PGF patients compared with in GGF patients and HD. Together, these data suggest that significant differences exist in the number of BM MФs, especially in the pattern of M1/M2 monocyte polarization, between patients with PGF and GGF after allo-HSCT. Impaired quantity and function of 7-day cultivated BMMo-MФs from PGF patients
To evaluate the quantity and function of primary BMMoMФs that were derived from PGF patients, GGF patients or HD, the cell count, phagocytosis using DiI-AcLDL, and migration were analysed. BMMo-MФs from PGF patients were quantitatively reduced compared with those from GGF patients (Fig 4A) .
After incubation with DiI-AcLDL, the BMMo-MФs from the PGF patients showed significantly less DiI-AcLDL-positive staining than the BMMo-MФs from the GGF patients (Fig 4B; 51Á08 AE 5Á43% vs. 92Á88 AE 2Á86%, P = 0Á0003), indicating that the BMMo-MФs from the PGF patients had deficient phagocytic activity. Moreover, the 7-day cultivated BMMoMФs from the PGF patients showed significantly reduced migration compared with the BMMo-MФs from the GGF patients (Fig 4C; 17Á58 AE 3Á33 vs. 78Á54 AE 6Á24, P = 0Á0002).
Increased levels of apoptosis and ROS and the dysfunction of BM CD34 + cells cocultured with PGF BMMo-MФs
To investigate the effects of BMMo-MФs on BM CD34 + cells in vitro, we analysed apoptosis, the intracellular ROS levels and the CFU plating efficiency. BM CD34 + cells from HD, when cocultured with PGF BMMo-MФs, demonstrated significantly higher levels of apoptosis, including early apoptosis (Fig 5C; 12Á5 AE 1Á03% vs. 4Á53 AE 0Á69%, P = 0Á0002) and late apoptosis (Fig 5D; 14Á80 AE 1Á12% vs. 3Á54 AE 0Á84%, P = 0Á0002) than those cocultured with GGF BMMo-MФs. Compared with BM CD34 + cells cocultured with GGF BMMo-MФs, the levels of alive BM CD34 + cells exhibited marked reduction when cocultured with PGF BMMo-MФs (Fig 5F; 67Á25 AE 3Á94% vs. 93Á51 AE 1Á42%, P = 0Á0002). The intracellular levels of ROS in BM CD34 + cells cocultured with PGF BMMo-MФs were significantly higher than in BM CD34 + cells cocultured with GGF BMMo-MФs (Fig 5G; 31 154 AE 1879 vs. 13 143 AE 1449, P = 0Á0002). Moreover, the BM CD34 + cells from HD, when cocultured with PGF BMMo-MФs, had significantly lower CFU plating efficiencies for all types of haematopoietic progenitors (Fig 5H) , including CFU-E (10Á80 AE 1Á12 vs. 41Á9 AE 5Á40, P = 0Á0001); BFU-E (9Á90 AE 1Á06 vs. 27Á45 AE 2Á96, P < 0Á0001); CFU-GM (6Á15 AE 0Á83 vs. 15Á10 AE 1Á42, P < 0Á0001); and CFU-GEMM (0Á70 AE 0Á21 vs. 2Á70 AE 0Á39, P = 0Á0004), than those cocultured with GGF BMMo-MФs.
Increased levels of TNF-a and IL-12 and reduced levels of TGF-b are evident in PGF BMMo-MФs
The levels of intracellular cytokines in BMMo-MФs were determined by flow cytometry. The levels of intracellular TNFa (Fig 6A; 2562 AE 168 vs. 1533 AE 132Á6, P = 0Á0002) and IL-12 ( Fig 6B; 1540 AE 133Á5 vs. 998Á6 AE 140Á1, P = 0Á03) were significantly higher in the PGF BMMo-MФs than in the GGF BMMo-MФs. TGF-b levels (Fig 6C; 656Á1 AE 65Á72 vs. 1648 AE 156Á9, P = 0Á0002) were remarkably lower in the PGF BMMo-MФs than in the GGF BMMo-MФs. The levels of TNF-a in the culture supernatants were also determined. Consistent with the flow cytometry data, more TNF-a was secreted by PGF BMMo-MФs (Fig 6D; 1296 AE 19Á07 pg/ml vs. 575Á9 AE 62Á39 pg/ml, P = 0Á0002) than by GGF BMMo-MФs.
Elevated p-p38 MAPK in BM CD34 + cells cocultured with PGF BMMo-MФs Notably higher levels of intracellular p-p38 (1387 AE 102Á9 vs. 656Á9 AE 81Á23, P = 0Á0002) and p-JNK (2926 AE 163Á7 vs. 1438 AE 112Á9, P = 0Á0002) were detected in BM CD34 + cells cocultured with PGF BMMo-MФs (Fig 6E-G) . In contrast, the levels of intracellular p-ERK (640Á3 AE 34Á37 vs. 721Á3 AE 31Á03, P = 0Á16) were not significantly different between the CD34 + BM cells cocultured with PGF BMMoMФs and those cocultured with GGF BMMo-MФs.
Discussion
The current study demonstrated an unbalanced BM M1/M2 polarization, characterized by increased M1 and decreased M2 in the BM of PGF patients following allo-HSCT. Moreover, BM MФs derived from PGF patients exhibited decreased capacities of proliferation, migration and phagocytosis; high expression of TNF-a and IL-12; and low expression of TGF-b, leading to the dysfunction of BM CD34 + cells through p38 MAPK pathway upregulation.
Emerging evidence from murine studies shows that MФs play essential roles in regulating haematopoiesis in the BM microenvironment. It has been reported that a subset of BM MФs functions in the maintenance and retention of HSCs through mesenchymal stem cells in BM (Chow et al, 2011; Ludin et al, 2012) . Moreover, tissue resident BM MФs can support erythropoiesis (Chow et al, 2013) . Additional studies have demonstrated that BM MФs play roles in bone maintenance, repair and resorption functions (Li et al, 2000; Luchin et al, 2001; Takayanagi et al, 2002) ; support the growth and survival of osteoblasts; and inhibit HSC mobilization to maintain HSC retention (Winkler et al, 2010; Christopher et al, 2011) . Ludin et al (2012) reported that BM-resident MФs and monocytes are adjacent to HSCs and that these MФs support the maintenance and protection of HSCs from exhaustion during stress. In addition, MФs can support proerythroblast proliferation in erythroblastic islands (Manwani & Bieker, 2008 ). In the current study, BM MФs were quantitatively and functionally dysregulated in PGF patients, and the ability of BM MФs to support haematopoietic progenitors was impaired, as determined by CFU plating efficiency assays in vitro. Considering the crucial roles of BM MФs in supporting haematopoiesis and the results of the current (Mercier et al, 2011) . MФs are a heterogeneous group, and their phenotypes and functions are regulated by the surrounding microenvironment (Moghaddam et al, 2018) . M1 mediate tissue damage and initiate inflammatory responses, whereas M2 are essential players in the resolution of inflammation (Mantovani et al, 2013; Das et al, 2015) . The M1/M2 balance plays a key role in regulating the immune system under normal conditions and is involved in many autoimmune diseases. In rheumatoid arthritis, TNF-a produced by M1 triggers cytokine production by synovial cells, leading to the development of chronic polyarthritis (Udalova et al, 2016) . Moreover, abnormal intestinal CD68 + MФs play a central role in Th1-or Th17/Th1-skewed intestinal inflammation in human Crohn disease via IL-23 and TNF-a (Kamada et al, 2008) . Collectively, the evidence shows that changes in MФ differentiation, polarization, and activation in the local milieu can play a decisive role in the pathogenesis of autoimmune and inflammatory diseases. Recently, we reported that elevated BM Th1/Th2 and Tc1/Tc2 ratios were involved in the occurrence of PGF Kong et al, 2017) . Consistent with the previous reports and our previous work, we found an aberrant monocyte distribution and MФ polarization towards M1 in the BM of PGF patients. Moreover, BM MФs from PGF patients showed increased production of TNF-a and IL-12 and decreased production of TGF-b, which gave rise to a type 1 response. Therefore, our results indicate that an unbalanced M1/M2 ratio, with increased pro-inflammatory cytokines in the BM immune microenvironment, is involved in the occurrence of PGF.
Increasing studies have demonstrated that pro-inflammatory cytokines are involved in causing abnormal haematopoietic development. TNF-a can activate p38 MAPKs, which suppress normal haematopoietic clones and regulate HSCs apoptosis in myelodysplastic syndromes. Fanconi anaemia patients are often found to overproduce TNF-a, which may directly affect HSC function by impairing HSC survival, homing and proliferation or indirectly change the BM microenvironment, thereby contributing to disease progression (Du et al, 2014) . In agreement with this, previous studies have demonstrated that TNF-a can negatively regulate the growth of murine and human haematopoietic progenitors, including HSCs (Broxmeyer et al, 1986; Backx et al, 1991; Rusten et al, 1994; Zhang et al, 1995) . Our experimental evidence demonstrated that the TNF-a levels were much higher in the supernatants of BM CD34 + cells cocultured with PGF BM MФs than in those cocultured with GGF BM MФs. Furthermore, the function of BM CD34 + cells cocultured with PGF BM MФs was significantly impaired, and this impairment was related to p38 MAPK pathway activation. Thus, MФ polarization towards M1 with a high level of TNF-a may aggravate pancytopenia in PGF patients. Recent progress has been made in understanding the molecular mechanism underlying the polarized activation of MФs, including members of peroxisome proliferators-activated receptors (PPARs), signal transducers and activators of transcription, and hypoxia inducible factor families (Wynn et al, 2013) . Selected clinically approved therapeutic strategies, such as PPARc inhibitors and statins, and preventive activities, such as weight loss, may have effects on the function of MФs (Sica & Mantovani, 2012) . Although requiring further validation, our preliminary data suggest that balancing the M1/M2 ratio and enhancing the function of BM MФs based on pathophysiology may appear to be attractive therapeutic strategies for PGF patients in the future.
Our previous reports indicate that dysregulated Th1 cell/ Th2 cell, Tc1 cell/Tc2 cell, and Th17 cell/Treg ratios in the BM immune microenvironment are involved in the pathogenesis of PGF Kong et al, 2017 ). In the current study, MФs reached unbalanced polarization states that were similar to the Th1/Th2 polarization state, which represents an activated immune state. However, we are aware that the pathogenesis of PGF is heterogeneous. Whether the impaired BM MФs directly affect haematopoiesis or act through their immunoregulatory effects on other immune cells in the occurrence of PGF requires further clarification.
In summary, these results indicate that an unbalanced BM M1/M2 ratio and dysfunctional BM MФs may play roles in the pathogenesis of PGF. BM CD34 + cells were functionally impaired when cocultured with PGF BM MФs through p38 MAPK pathway upregulation. Although further validation is required, these findings indicate that balancing the M1/M2 ratio and enhancing the function of BM MФs are promising therapeutic approaches for PGF patients after allo-HSCT.
